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Psychological Stress and Immune Function
Allison Rubin

The medical community has always acknowledged that psychological stress can affect
physical well-being, even though the mechanism was not always known. Now we know that this
phenomenon is mediated by the body’s response to external stress, which originates in the
central nervous system (CNS). The limbic system of the CNS is involved in adaptation, the
process by which humans adapt physically and emotionally to a new environment, and
organizing neuroendocrine and emotional responses to stressful stimuli. “The limbic system
evaluates the stressful signals and compares them with stored information collected from past
experience. Within the system the septo- hippocampal cholinergic structure is heavily engaged in
adaptation processes to stressful conditions” (Khansari, Murgo, & Faith, 170). Therefore, the
extent to which the body responds physiologically to stress is in part due to the way the
individual is capable of coping with stress. A person who does not handle stress appropriately
may have stronger/longer responses, which can trigger the HPA axis to produce cortisol and the
SNS to release norepinephrine. Cortisol and norepinephrine ultimately cause repression of the
immune system (O’Connor, O’Halloran, & Shanahan, 2000; Webster, Tonelli, & Sternberg,
2002).
Several studies have illustrated the effects of stress on immune functioning. Glaser et al.
(1998) found a decreased antibody response to vaccination among caregivers of Alzheimer’s
disease patients. Additionally, Workman and La Via (1987) found that medical students taking
national board examinations had significantly lower T-lymphocyte proliferation than less
stressed individuals.
The relationship between a stressful life and decreased immune functioning is especially
important for the already immunosuppressed HIV population. In human HIV, studies have
shown that psychological stress is associated with decreased helper T cell and B cell counts
(Motivala et al., 2003). Petitto et al. (2000) found that increased cortisol levels were associated
with lower amounts of CD8+ and NK cells in medication-free HIV+ men. In addition, Goodkin
et al. (1992) discusses how homosexual men with a more passive coping style and more life
stressors have lower numbers of helper T lymphocytes than men with an active coping style and
less life stressors.
Not only can psychological stress cause further suppression of the immune system but it
can also contribute to reactivation of HIV during latent stages of infection. HIV is characterized
by a period of latency that can last several years. However, some HIV+ individuals develop
health problems (opportunistic infections, secondary cancers, HIV related mental deficits, etc.)
rapidly. It is thought that certain “co-factors” are involved in determining the rate of immune
dysfunction for an individual. Co-factors are defined as the number of exposures to HIV, genetic
predisposition to retroviral infection, infection with other viruses that may activate HIV, and age
(Gorman & Kertzner, 1990). Currently, psychological and social factors are not completely
accepted as co-factors in HIV progression. However, there are many studies that implicate the
effects of stress hormones on the proliferation of HIV. For example, the ability of HIV to infect
human monocytes and lymphocytes was enhanced by the addition of hydrocortisone (Gorman &
Kertzner, 1990). Additionally, cortisol can combine with gp-120, the envelope protein of HIV-1
that is discarded during infection, to induce apoptosis in normal lymphocytes (Nair et al., 2000).
Evans et al. (1997) found that higher severe life stress increased the odds of developing HIV
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disease progression nearly four fold and is associated with an increased rate of early disease
progression.
Additionally, the HIV population is susceptible to unique life stresses that have been
shown to contribute to immunosuppresion. For example, the Highly Active Antiretroviral
Therapy (HAART) has strict guidelines for food intake, the number of doses required a day, and
dosing times. While having a significant impact on reducing HIV progression, these guidelines
also produce chronic stressors such as coping with side effects, the economic strain of paying for
treatment, and major shifts in life schedules and tasks (Safren et al., 2002). Although some may
argue that these stressors have limited effects because HAART slows disease progression, Safren
et al. (2002) suggest that HAART can negatively impact quality of life and cause patients to have
low adherence to the regimen. This can have a drastic effect on HAART’s success because even
low levels of nonadherence have been related to faster disease progression (Chesney et al.,
2000).
Another significant stress is the social stigma related to HIV. “Social rejections,
disapproval, and discrimination related to HIV may heighten a person’s sense of shame
regarding their illness and serve to lessen their motivation to maintain optimal health” (Vanable
et al., 474). The social stigma associated with HIV is propagated by the fact that many people are
misinformed and uneducated about disease transmission. One in four Americans are afraid of
interactions with HIV+ individuals and one in three Americans say they would actively avoid
contact with HIV+ people (Vanable et al., 2006). Schmitz and Crystal (2000) suggest that
stigmatization leads to decreased social support because of rejection by family members and
discrimination based on HIV status. This is important because decreased social support is
associated with accelerated HIV progression (Lesserman et al., 1999). In addition, Vanable et al.
(2006) found that stigmatization is linked to greater subjective reports of HIV related symptoms
but not viral load. They also discovered that the social stigma surrounding HIV is correlated with
depressive symptoms. Depression has been correlated with immunosuppression in HIV+ males.
For example, Burack et al. (1993) found a significant relationship between depression and a
reduction of helper T cells in HIV+ men. Furthermore, the fear of being stigmatized may prevent
people from being tested for HIV permitting them to spread the disease to others.
HIV+ individuals can also suffer from Posttraumatic Stress Disorder (PTSD) after
learning about their diagnosis. Ironson et al. (1997) found that post traumatic stress symptoms
(after Hurricane Andrew) were related to decreased amounts of helper T cells, cytotoxic T cells,
and natural killer cell cytotoxicity. Although the relationship between PTSD and immune
function is still unclear, PTSD is associated with decreased adherence to HAART therapy and
consequently increased viral load (Delahanty, Bogart, & Figler, 2004). Taking medication may
remind HIV+ individuals with PTSD of the traumatic diagnosis and bring unwanted attention
from peers. The social stigma surrounding HIV may also contribute to PTSD after diagnosis.
HIV+ individuals also experience extreme psychological distress following the death of
close friends with HIV. Kessler et al. (1991) determined that HIV seropositve men reported more
deaths from AIDS in their social networks than seronegative men. Not only are HIV+ people
grieving for the loss of their friends, but they are also watching their peers die of the same
disease that could eventually cause their own demise. Goodkin et al. (1996) found that decreased
natural killer cell cytotoxicity and lymphocyte proliferation was associated with bereavement in
HIV+ homosexual men.
HIV infected individuals are at a high risk of depression because of the enormous amount
of stresses in their lives. Nearly 38% of HIV patients have anxiety disorders (Basu, Chwastiak, &
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Bruce, 2005). Depression can negatively impact the immune system and have dire consequences
for HIV+ people. It is associated with increased mortality (including nonsuicidal mortality),
increased incidence of heart attacks, and higher odds of death from cancer (Gorman & Kertzner,
1990). Appropriate treatment for depression is necessary in HIV+ individuals because depressive
symptoms can mask somatic symptoms of HIV. Depression also contributes to relapse into drug
abuse, which is a prominent problem among HIV+ patients.
HIV+ individuals face an enormous amount of stress everyday either relating to the
disease itself or the stigma surrounding HIV. Although the relationship between these variables
and disease progression is still not well understood, there have been a number of studies that
have shown the effectiveness of interventions on the well-being of HIV+ patients.
The interventions generally focus on behavioral changes and increased social support.
This is the case because, as examined by Wolf et al. (1991), active behavioral coping is
associated with greater perceived social support and improved mood while avoidance coping is
associated with lower social support and mood disturbance. Mulder et al. (1995) used cognitive
behavioral group therapy and experiential group therapy to decrease psychological distress,
depressive symptoms, and psychiatric symptoms among HIV+ homosexual men. The program
lasted for 15 weeks and decreases in distress were related to increases in CD4+ cell counts.
Similarly, HIV+ individuals that participated in a structured 8 week Mindfulness-Based Stress
Reduction (MBSR) Program showed increased natural killer cell activity. This program
emphasized the importance of self-observation, moment-to-moment awareness, and
concentration. It used awareness exercises, meditation, and yoga to teach the importance of selfawareness and its application (Robinson, Mathews, & Witek-Janusek, 2003). Additionally,
enhanced social support from clinicians and the community and modification of individual risk
behaviors enhanced the quality of life among HIV+ individuals (Liu et al., 2006).
Depression is also an important area for intervention as it is prevalent among the HIV+
community and may contribute to disease progression. Therefore effectively coping with
depression is crucial. Cruess et al. (2005) found that the resolution of depression among HIV+
women was associated with increased natural killer cell activity. In order to effectively cope with
depression an individual may seek social support, the guidance of a psychologist, or even the
effects of antidepressants. However, HIV+ individuals must be careful not to use medications
that increase norepinephrine levels that may impair lymphocyte function (Gorman & Kertzner,
1990).
While the previous interventions focus directly on managing stressful life events and
depressive symptoms, other studies examine the effects of secondary lifestyle choices on HIV
disease progression. For example, Tuck et al. (2001) found that spirituality was positively related
to quality of life, social support, effective coping strategies, and negatively related to perceived
stress, uncertainty, psychological distress and emotional-focused coping. Also, massage therapy
and exercise have been correlated with enhanced immune functioning and slower disease
progression among HIV+ individuals (Ironson et al., 1996; Mustafa et al., 1999).
HIV disease progression is a multivariate phenomenon encompassing the damaging
effects the virus has on the immune system and its regulatory processes, and the effects of HIV
specific psychological factors on immune functioning. Therefore, a widespread body of research
is needed in order to better understand the complicated relationships between the external
environment, the brain, and the immune system. It is possible that once the link between life
stresses and HIV disease reactivation is understood that specific medications and interventions
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may be developed to help maintain the period of latency experienced early on. Psychological
interventions and alternative therapies could become an integral part of HIV treatment.
There is an abundance of research that shows psychological stress has profound
consequences for patients with any disease. Therefore, it seems likely that stress could contribute
to pathology, or make one more prone to disease. This is an important possibility and should be
considered when treating both sick and healthy patients. Future physicians and physicians alike
should not overlook the role stress plays in disease progression or the effectiveness of
psychological interventions and alternative therapies on both the emotional and physical well
being of their patients.
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